Driving Simulation to Assess Non-Sedative Effects of Tolperisone

Phase 1 Completed 35 enrolled Neurana Pharmaceuticals, Inc. Cognitive Research Corporation · collab

RandomizedCrossoverTriple-blindTreatment

Summary

This is a randomized blinded study to assess the sedative effect of 150 mg TID tolperisone and 10 mg TID cyclobenzaprine compared to placebo on simulated driving performance and cognitive functioning in healthy adult volunteers.

Timeline

Start: 2017-07-31
Primary completion: 2017-12-06
Completion: 2018-01-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	cyclobenzaprine	Small molecule	10 mg	—

Indications

No indication recorded.